BioCentury
ARTICLE | Clinical News

Lebrikizumab: Phase III data

March 7, 2016 8:00 AM UTC

Top-line data from the identical, double-blind, international Phase III LAVOLTA I and LAVOLTA II trials in >2,100 patients total with severe uncontrolled asthma despite treatment with inhaled corticos...